Citigroup’s SBC Medical Group SBC Stock Holding History
Bought
Maintained
Sold
Other funds holding SBC
SS
CPBTD
WN
AHL
SCM
EWA
FFA
SIC
TWD
Citigroup's SBC Position: Q2 2026 in Review
Citigroup increased its SBC Medical Group (SBC) stake by 1,403% in Q2 2026, buying an estimated $28.3K and bringing the position to 8,930 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5104.
Citigroup first reported a position in SBC in Q2 2025 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold SBC as of Q2 2026.
- Citigroup held 8,930 shares of SBC Medical Group worth $27.5K as of Q2 2026.
- Citigroup bought 8,336 SBC Medical Group shares in Q2 2026, an estimated $28.3K.
- SBC Medical Group made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5104 holding.
- Citigroup first reported a position in SBC Medical Group in Q2 2025 and has held it in 5 quarters since.
- 12 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.